{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:18Z","timestamp":1759333638836},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.det.2010.01.009","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T07:18:40Z","timestamp":1273043920000},"page":"283-287","source":"Crossref","is-referenced-by-count":19,"title":["Treatment of Skin Cancers in Epidermolysis Bullosa"],"prefix":"10.1016","volume":"28","author":[{"given":"Supriya S.","family":"Venugopal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2010.01.009_bib1","first-page":"206","article-title":"Premature death and inherited epidermolysis bullosa","volume":"vol. 1","author":"Fine","year":"1999"},{"issue":"2","key":"10.1016\/j.det.2010.01.009_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.01.009_bib3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/sj.jid.5700939","article-title":"Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis","volume":"127","author":"Rodeck","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0625.2007.00563.x","article-title":"Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"16","author":"Rodeck","year":"2007","journal-title":"Exp Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.01.009_bib5","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/sj.jid.5700878","article-title":"Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression","volume":"127","author":"Pourreyron","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.009_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0560.1992.tb01352.x","article-title":"Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases","volume":"19","author":"McGrath","year":"1992","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.det.2010.01.009_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.0022-202X.2004.22525.x","article-title":"Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa","volume":"122","author":"Mallipeddi","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03401916","article-title":"Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Arbiser","year":"1998","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.det.2010.01.009_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.0022-202X.2004.23418.x","article-title":"Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"123","author":"Arbiser","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2010.01.009_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0001-7310(06)73457-3","volume":"97","author":"Garcia-Morales","year":"2006","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"10.1016\/j.det.2010.01.009_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.bcr.0000176967.74674.64","article-title":"Very acute and aggressive form of Marjolin's ulcer caused by single blunt trauma to the burned area","volume":"26","author":"Copcu","year":"2005","journal-title":"J Burn Care Rehabil"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0194-5998(03)00363-2","article-title":"Marjolin's ulcer arising in a previously grafted burn of the scalp","volume":"128","author":"Wong","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002560100355","article-title":"Malignancy in chronic ulcers and scars of the leg (Marjolin's ulcer): a study of 21 patients","volume":"30","author":"Smith","year":"2001","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.det.2010.01.009_bib14","first-page":"49","article-title":"Marjolin's ulcer arising in a burn scar","volume":"62","author":"Dupree","year":"1998","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00004630-199105000-00004","article-title":"Malignancy and chronic wounds: Marjolin's ulcer","volume":"12","author":"Fishman","year":"1991","journal-title":"J Burn Care Rehabil"},{"issue":"5","key":"10.1016\/j.det.2010.01.009_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2133.2003.05270.x","article-title":"Squamous cell carcinoma developing in a 12-year-old boy with nonHallopeau-Siemens recessive dystrophic epidermolysis bullosa","volume":"148","author":"Kawasaki","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.01.009_bib17","series-title":"Photographic monitoring for squamous cell carcinoma in RDEB. Proceedings of the International EB Professionals Congress","author":"Murrell","year":"2003"},{"issue":"4","key":"10.1016\/j.det.2010.01.009_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2003.08.008","article-title":"Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin","volume":"50","author":"Fine","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.009_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(03)01837-1","article-title":"Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: histologic and immunohistochemical effects","volume":"50","author":"Smit","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.det.2010.01.009_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/jdt.14.s2.3.6","article-title":"Acitretin suppression of squamous cell carcinoma: case report and literature review","volume":"14","author":"Lebwohl","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.det.2010.01.009_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2010.01.009_bib22","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"Ahypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2133.2005.06783.x","article-title":"Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa","volume":"153","author":"Souza","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.01.009_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00042728-200601000-00029","article-title":"Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa","volume":"32","author":"Saxena","year":"2006","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1346-8138.2008.00479.x","article-title":"Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa","volume":"35","author":"Rokunohe","year":"2008","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.01.009_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/archderm.141.1.110","article-title":"Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma","volume":"141","author":"Perez-Naranjo","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.01.009_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-b","article-title":"Possible role of sentinel node biopsy in the management of squamous cell carcinomas in inherited epidermolysis bullosa","volume":"140","author":"Fine","year":"2004","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.det.2010.01.009_bib28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1745-7254.2007.00681.x","article-title":"Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives","volume":"28","author":"Zhu","year":"2007","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"10.1016\/j.det.2010.01.009_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/CAD.0b013e32809ef9e0","article-title":"Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab","volume":"18","author":"Suen","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.bjc.6603566","article-title":"Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck","volume":"96","author":"Reuter","year":"2007","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CCO.0b013e3282f9b575","article-title":"Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck","volume":"20","author":"Le Tourneau","year":"2008","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hoc.2008.08.002","article-title":"Molecularly targeted agents in the treatment of recurrent or metastatic squamous cell carcinomas of the head and neck","volume":"22","author":"Le Tourneau","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"16","key":"10.1016\/j.det.2010.01.009_bib33","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2006.06.7447","volume":"25","author":"Vermorken","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.det.2010.01.009_bib34","first-page":"731","article-title":"PTEN expression controls cellular response to cetuximab by mediating PI3K\/AKT and RAS\/RAF\/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells","volume":"21","author":"Bouali","year":"2009","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.det.2010.01.009_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.det.2010.01.009_bib36","article-title":"Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: preliminary results of a phase II multicenter study","volume":"26","author":"Maubec","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:58Z","timestamp":1559072938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0733863510000100"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.01.009","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}